Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hip OA

Psoriatic Arthritis: A Look Back at Moll & Wright’s Landmark 1973 Paper

Ruth Jessen Hickman, MD  |  May 17, 2019

Psoriatic arthritis came to be viewed as a distinct disease entity with specific clinical features, genetics and pathophysiology only gradually. One important historic development in this transition was a 1973 paper written by a pair of researchers out of Leeds, England: John M. Moll, BSc, DM, and Verna Wright, MD, FRCP.1 Here we discuss the…

Filed under:ConditionsPsoriatic Arthritis Tagged with:Classification CriteriaClassification of Psoriatic Arthritis (CASPAR)criteriaLost & FoundMoll and Wright criteriaPsoriatic Arthritis

MicroOne / shutterstock.com

Rheumatology Drugs at a Glance, Part 2: Psoriasis

Mary Choy, PharmD, BCGP, FASHP  |  May 17, 2019

Over the past few years, bio­similars and other new drugs have been introduced to treat rheumatic illnesses. Some of the conditions we treat have numerous drug option; others have few or only off-label options. This series, “Rheumatology Drugs at a Glance,” provides streamlined information on the administration of biologic, biosimilar and other medications used to…

Filed under:ConditionsDrug Updates Tagged with:adalimumabapremilastbrodalumabCertolizumab Pegoletanerceptguselkumabguttate psoriasisinfliximabinverse psoriasisixekizumabPsoriatic Arthritispsoriatic erythrodermapustular psoriasisRheumatic Drugs at a Glancesecukinumabtildrakizumabustekinumabvulgar psoriasis

ACR/ARP Members Educate Lawmakers

Ryan Basen  |  May 17, 2019

Dozens of rheumatology leaders met with more than 100 politicos on Capitol Hill in mid-May, per the ACR’s annual Advocacy Leadership Conference. Armed with research and advocacy training concerning a handful of important issues, rheumatologists, researchers, government affairs specialists and others met with federal lawmakers, legislative aides and correspondents. The two-day conference, which featured the…

Filed under:Education & TrainingLegislation & AdvocacyMeeting Reports Tagged with:Washington D.C.

How to Address the Rheumatology Workforce Gap

Paul H. Caldron, DO, PhD, MBA, FACP, FACR  |  May 17, 2019

The College’s principal journals have been telling the tale of workforce woe, exploring the reasons for our predicament and potential solutions for the long and short term.1,2 Among the medium-term remedies is increased use of advanced practice clinicians (APCs), as we collectively refer to nurse practitioners and physician assistants in rheumatology practices. Solutions Estimates of…

Filed under:Practice SupportSpeak Out RheumWorkforce Tagged with:Advanced Practice Cliniciansnurse practitionerphysician assistantsSpeak Out Rheumatologyturnoverworkforce shortage

An Expression of Gratitude: The Presidents’ Farewell to Mark Andrejeski

Paula Marchetta, MD, MBA  |  May 17, 2019

Sometimes it’s hard to get a song out of your head, especially when you can’t recall all the lyrics and struggle to find the words to fill in the blanks. That’s what happened to me when I started to write this column. A song, probably too dated now for many to find particularly compelling, kept…

Filed under:President's Perspective Tagged with:American College of Rheumatology (ACR)Mark Andrejeski

Table Stakes: The Right to Healthcare

Philip Seo, MD, MHS  |  May 17, 2019

Table stakes. It took me a moment to register what they were talking about. I was listening to Pod Save America, a wildly popular podcast put together by some of Barack Obama’s former speechwriters. It is, I imagine, what an MSNBC podcast might sound like if Rachel Maddow and Chris Hayes were allowed to swear….

Filed under:OpinionRheuminationsSpeak Out Rheum Tagged with:Medicare for AllOpinion

Hanna Kuprevich / shutterstock.com

How to Help Your Patients Find Credible Information about Their Disease

Catherine Kolonko  |  May 17, 2019

Where can patients obtain more information about their diagnoses and prescription drugs, and answers to the assortment of questions they have about living with a chronic disease once they leave the rheumatologist office? Patient education materials can be found in many places on the internet, but those looking for answers may need a helping hand…

Filed under:Patient Perspective Tagged with:patient communicationpatient knowledgepatient resources

History of Infection Linked to Primary Sjögren’s Syndrome

Carina Stanton  |  May 14, 2019

In a recent investigation of Swedish patients, environmental triggers of the immune system are a common factor for patients with primary Sjögren’s syndrome…

Filed under:ConditionsOther Rheumatic ConditionsSjögren’s Disease Tagged with:Infectionpatient historySjogren's

Insights into Celiac Disease & Systemic Autoimmune Diseases

Lara C. Pullen, PhD  |  May 14, 2019

Little is known about the immunopathogenic relationship between celiac disease and systemic autoimmune diseases, such as primary Sjögren’s syndrome and systemic sclerosis. But new research indicates that screening for celiac disease may benefit patients newly diagnosed with systemic autoimmune diseases, as well as supports the idea that celiac disease may accelerate the development of systemic autoimmune disease…

Filed under:ConditionsOther Rheumatic ConditionsSjögren’s Disease Tagged with:celiac diseasescreeningSjogren'sSystemic sclerosis

Characterization of Autoreactive B Cells in Patients with SLE & RA

Lara C. Pullen, PhD  |  May 6, 2019

Antibody-secreting cells are important for the pathophysiology of SLE and RA, but researchers have been unable to determine how these cells are activated. A new technique is able to distinguish between naïve autoreactive B cells and established antibody secreting cells…

Filed under:ConditionsRheumatoid ArthritisSystemic Lupus Erythematosus Tagged with:autoreactive B cellsRheumatoid Arthritis (RA)systemic lupus erythematosus (SLE)

  • « Previous Page
  • 1
  • …
  • 142
  • 143
  • 144
  • 145
  • 146
  • …
  • 326
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences